T1	intervention 15 24	tamoxifen
T2	ethinicity 69 74	asian
T4	location 408 414	Taiwan
T6	total-participants 659 664	3,690
T7	age 705 714	50.1Â±11.3
T8	intervention-participants 717 722	2,056
T9	control-participants 754 759	1,634
T10	outcome 853 869	incidence of AMI
T11	iv-bin-percent 871 876	0.15%
T12	cv-bin-percent 881 886	0.67%
T13	outcome 898 913	ischemic stroke
T14	iv-bin-percent 915 920	1.99%
T15	cv-bin-percent 925 930	3.30%
T16	outcome 942 960	hemorrhagic stroke
T17	iv-bin-percent 962 967	0.15%
T18	cv-bin-percent 972 977	0.55%
T19	outcome 993 1020	total cardiovascular events
T20	iv-bin-percent 1022 1027	2.24%
T21	cv-bin-percent 1032 1037	4.16%
T22	outcome 1165 1194	risk of myocardial infarction
T25	outcome 1260 1275	ischemic stroke
T28	outcome 1305 1323	hemorrhagic stroke
T31	outcome 1357 1384	total cardiovascular events
T3	control 760 767	did not
T5	outcome-Measure 535 582	occurrence of acute myocardial infarction (AMI)
T23	outcome-Measure 584 614	ischemic or hemorrhagic stroke
T24	outcome-Measure 619 646	total cardiovascular events
